Atopic dermatitis is a chronic skin condition affecting millions worldwide. However, patients are not only burdened physically but also emotionally. Frustration, isolation, anxiety, distress... these are some of the feelings they experience during their emotional journey. In our commitment to patients' wellbeing and in support of #GlobalSkin, we are excited to announce the launch of “The True Colors of Atopic Dermatitis” for Global Atopic Eczema Day. This initiative aims to showcase the real feelings of those living with atopic dermatitis and bring visibility to their reality, without filters. Get ready to discover the full color palette of feelings on 14th September! #AtopicDermatitis #truecolorsunfiltered #WorldAtopicEczemaDay #AtopicEczemaUnfiltered
Sobre nosotros
Almirall is a global biopharmaceutical company focused on medical dermatology. Founded in 1944 and with headquarters in Barcelona (Spain), our purpose is at the core of our work: “Transform the patients’ world by helping them realize their hopes and dreams for a healthy life”. Through pharmaceutical innovation, investment in R&D and strong commitment to global healthcare partnerships, we develop and commercialize solutions with specific focus on dermatological diseases such as psoriasis, actinic keratosis, atopic dermatitis or acne. We care and listen to our patients’ needs. We find solutions for them. We aim to empower them. Almirall has 1 R&D center, 2 chemical plants and 2 pharmaceutical plants. Our more than 1,900 employees make it possible for our treatments to be available in over 100 countries across 5 continents, through our 15 global affiliates and via a strategic partnership network. Almirall is listed on the Spanish Stock Exchange (ticker: ALM).
- Sitio web
-
http://www.almirall.com
Enlace externo para Almirall
- Sector
- Fabricación de productos farmacéuticos
- Tamaño de la empresa
- De 1.001 a 5.000 empleados
- Sede
- Barcelona
- Tipo
- Empresa pública
- Fundación
- 1944
- Especialidades
- Dermatology (Actinic keratosis, Atopic Dermatitis, Eczema, Inflammatory Skin Conditions, Psoriasis, Rosacea, Severe Acne), OTC Products, Other Specialty Areas (e.g. Spasticity in Multiple Sclerosis) y Medical Device
Ubicaciones
-
Principal
Ronda General Mitre, 151
Barcelona, 08022, ES
-
Carretera Laureà Miró, 408
Sant Feliu de Llobregat, Barcelona 08980, ES
-
Carretera de Martorell 41-61
Sant Andreu de la Barca, Barcelona 08740 , ES
Empleados en Almirall
Actualizaciones
-
🎉This year at Almirall, we celebrate our 80th anniversary. Over the past 8 decades, we’ve grown from developing medicines at a small site in Barcelona to a global leader in the pharmaceutical industry, with 2,000 employees across Europe and the US. As a family-owned company, our legacy is grounded in a long-term vision of creating innovative solutions that support people living with diseases and the medical community. Let’s celebrate our 80 years of achievements as a foundation for our future. Discover our history at https://lnkd.in/dZZXY5XR #Almirall80Years #WeAreAlmirall
-
Dry skin is often associated with cold's winter weather, but what many people don't know is that the heat of summer's dry air also causes dry skin. Proper skin hydration is essential for those living with atopic dermatitis, a chronic skin condition characterized by dryness. A good skin care routine that includes daily bathing and moisturizing is essential for managing AD symptoms and preventing flares. For more information, visit https://lnkd.in/d7c55bhY #AtopicDermatitis #MedicalDermatology
-
💡 Innovation is the cornerstone of our success. Our collaborative approach enables us to partner closely with leading experts worldwide to develop groundbreaking technologies, including AI-based drug discovery or mRNA-based therapies. Our Senior Director of Data Science, Francesc Fernández, discusses some of these R&D collaborations with our Chief Scientific Officer, Karl Ziegelbauer. Watch the full video here: https://lnkd.in/d8SZu4Kc #Innovation #MedicalDermatology #YearInReview
-
Triggers for atopic dermatitis include exposure to allergens such as pollen, pet dander, or peanuts, as well as stress, dry skin, or infections. At Almirall, we understand the complex relationship between atopic dermatitis and allergies. Through innovation and collaboration with patient associations and the dermatological community, we seek to continue to move towards a better future for people with atopic dermatitis. For more information, visit https://lnkd.in/d7c55bhY #AtopicDermatitis #MedicalDermatology
-
-
Last month, we introduced #Act4Impact, our updated sustainability strategy setting ambitious targets for 2030. This comprehensive approach is at the heart of our decision-making and aligned with our purpose of transforming patients' lives. Sustainability News interviewed our Global Sustainability Senior Manager, Cristina Raventós, to discuss the pharmaceutical industry’s sustainability journey and how our Act4Impact strategy is driving positive change. Read the full interview here: https://lnkd.in/e2iEhDSm #Act4Impact
-
-
Technologies such as #mRNA are set to transform the industry and the way drugs are developed. This technology, which gained momentum during the pandemic and is now increasingly seen as a valuable therapeutic modality, could help address current unmet medical needs from different angles at once. Last year, we entered into a multi-target alliance with etherna to discover and develop novel mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. The flexibility of mRNA technology will allow us to explore new therapeutic hypotheses in different disease indications and help us move closer to our purpose of improving people's lives. #Innovation #MedicalDermatology
-
-
Don't let myths about actinic keratosis put your skin at risk this summer! 🔹Myth 1: Actinic keratosis isn’t dangerous. 🔹Myth 2: Actinic keratosis does not require treatment. 🔹Myth 3: Skin cancer is not life-threatening. The truth is that actinic keratosis is a precancerous condition that may turn into squamous cell carcinoma if untreated. Skin cancer is the most common form of cancer in the United States and can be life-threatening. Protect your skin this summer by being aware of the dangers of actinic keratoses, and visit your doctor for an early diagnosis. For more information, you can visit: https://lnkd.in/dqcNzXaz #ActinicKeratosis #CheckYourSkin #StayVigilant
-
-
"This is a first step in better understanding the pathogenesis of hidradenitis suppurativa at the molecular level. We need to continue to build on these findings to generate new hypotheses for drug discovery on the road to finding new effective treatment options for patients suffering from HS," stated our Disease Biology scientists Marta Calbet and Ozge Uluckan. 📖Have you read our scientists' interview in Dermatology Times about the latest developments in our collaboration with the University of Michigan? Learn here how these research efforts pave the path towards addressing the unmet needs of people with skin diseases like HS and improve their wellbeing: https://lnkd.in/dsgay-6K #Innovation #MedicalDermatology #HidradenitisSuppurativa
-
-
Summer is here, so don't let actinic keratosis ruin your fun in the sun! 🚩These rough, raised bumps on your skin can be a red flag and a warning sign of something more serious. Actinic keratosis is a skin condition caused by prolonged exposure to UV rays from the sun and tanning beds. But don't worry; you can still enjoy the summer while protecting your skin. Reduce your risk by using sunscreen every day and limiting your exposure to the sun. Stay safe during this summer season! For more information, you can visit https://lnkd.in/dqcNzXaz #ActinicKeratosis #CheckYourSkin #StayVigilant
-
Páginas similares
Buscar empleos
Financiación
Última ronda
Equidad tras OPV215.792.796,00 US$